Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024

Rhea-AI Summary

Medpace Holdings, Inc. (MEDP) will release its first quarter 2024 financial results on April 22, 2024, followed by a conference call on April 23, 2024, at 9:00 a.m. ET. Interested parties can register in advance to join the call and access the webcast via the company's investor website.

CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024, at 9:00 a.m. ET to discuss these results.

To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call.

To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,900 people across 42 countries as of December 31, 2023.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240328685451/en/

Investor Contact:

Lauren Morris

513.579.9911 x11994

l.morris@medpace.com

Media Contact:

Julie Hopkins

513.579.9911 x12627

j.hopkins@medpace.com

Source: Medpace Holdings, Inc.

FAQ

When will Medpace Holdings, Inc. (MEDP) report its first quarter 2024 financial results?

Medpace Holdings, Inc. (MEDP) will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024.

When is the conference call scheduled to discuss Medpace Holdings, Inc. (MEDP) first quarter 2024 financial results?

The conference call to discuss Medpace Holdings, Inc. (MEDP) first quarter 2024 financial results is scheduled for Tuesday, April 23, 2024, at 9:00 a.m. ET.

How can interested parties participate in the conference call hosted by Medpace Holdings, Inc. (MEDP)?

Interested parties can participate in the conference call hosted by Medpace Holdings, Inc. (MEDP) by registering in advance via the provided link and joining the call 10 minutes prior to the event start.

Where can participants access the webcast of the conference call by Medpace Holdings, Inc. (MEDP)?

Participants can access the webcast of the conference call by Medpace Holdings, Inc. (MEDP) through the 'Investors' section of the company's website at investor.medpace.com.

Will there be a replay of the conference call by Medpace Holdings, Inc. (MEDP)?

Yes, a webcast replay of the conference call by Medpace Holdings, Inc. (MEDP) will be available at the same site approximately one hour after the end of the call.